Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05876533 · ClinicalTrials.gov registry record
R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances
A clinical trial of Chronic Heart Failure, sponsored by Cordio Medical.
- Active
- Registry status
- 216
- Enrollment target
- 8
- Study locations
NCT05876533: Active study of Chronic Heart Failure, sponsored by Cordio Medical.
NCT05876533 is a study of Chronic Heart Failure that is active but no longer recruiting, run by Cordio Medical. The registered enrollment target is 216 participants, below the 404-participant average among 12 other Chronic Heart Failure trials with a reported enrollment target (47% lower). The trial reports 8 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05876533, a study of Chronic Heart Failure, is active but no longer recruiting, sponsored by Cordio Medical.
- ACTIVE NOT RECRUITING
- Registry status
- 216 participants
- Enrollment target
- 8
- Study locations
Study Summary
To determine the usability and technical aspects of Cordio HearO™
Primary Outcome
The used scale is: Usability questionnaire for the Cordio HearO™ App. This Usability questionnaire is a subjective evaluation based on Likert score of device user satisfaction. Maximum value for each item: 5 Minimum value for each item: 1 Higher scores means a better outcome
Conditions Studied
Interventions
- DEVICE Cordio HearO
Study Locations (8)
Florida
- C&R Research Services - Cape Coral
- C&R Research Services - Miami
- C&R Research Services - Miami
Other
- Barzilai Medical Center- Cardiology - Ashkelon
- Heart Failure Clinic - Clallit Be'er Sheva - Beersheba
- Rabin Medical Center - Cardiology- CHF - Petah Tikva
Connecticut
- Kurker Family Medicine - South Windsor
Georgia
- Lake County Med Grp - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2022-03-18 |
| Est. Completion | 2025-03-15 |
What the registry record for NCT05876533 still lists
NCT05876533 is an observational study that tracks outcomes without assigning an intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 404-participant average among 12 other Chronic Heart Failure trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Chronic Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Cordio HearO is the first listed.
NCT05876533 lists 8 locations in 4 states (Florida, Other, Connecticut).
Frequently Asked Questions
What is clinical trial NCT05876533 about?
NCT05876533 is a clinical study titled "R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances". To determine the usability and technical aspects of Cordio HearO™
What is the current status of trial NCT05876533?
This trial is currently active not recruiting. The enrollment target is 216 participants. The study started on 2022-03-18. Estimated completion is 2025-03-15.
What conditions does trial NCT05876533 study?
This clinical trial studies the following conditions: Chronic Heart Failure.
What interventions are being tested in trial NCT05876533?
The interventions under investigation include: Cordio HearO (DEVICE).
Who is sponsoring clinical trial NCT05876533?
This trial is sponsored by Cordio Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05876533 being conducted?
This trial has 8 study locations across Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05876533's enrollment target sits among peer trials
216 6th of 12 higher than 7 of 12 other Chronic Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
RECRUITING · NA
-
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
RECRUITING · NA
-
Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment
RECRUITING · NA
-
The HEARTFELT Study
RECRUITING · NA
-
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
RECRUITING · Phase 3
-
Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02609685 · 216 participants · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI